IVF (INVO Fertility) Beta: 2.1584 (As of Jul. 11, 2026)


IVF INVO Fertility Inc IVF
35 GF Score
Price $1.13
GF Value $134.71
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is INVO Fertility Beta?

INVO Fertility IVF -2.59% 35 Beta is 2.1584 as of Jul. 11, 2026. GuruFocus rates IVF with a GF Score™ of 35/100 and a GF Value™ of $134.71 (Possible Value Trap). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-11), INVO Fertility's Beta is 2.1584.


INVO Fertility  (NAS:IVF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


INVO Fertility Beta Related Terms


INVO Fertility Beta Historical Data

* Premium members only.

The historical data trend for INVO Fertility's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

INVO Fertility Beta Chart

INVO Fertility Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 0.99 3.01 2.99 3.39

INVO Fertility Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.36 2.74 3.32 3.39 2.75

IVF vs RMSL, ADMT, USAQ: Beta Comparison

For the Medical Devices subindustry, INVO Fertility's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


INVO Fertility Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, INVO Fertility's Beta distribution charts can be found below:

* The bar in red indicates where INVO Fertility's Beta falls into.


IVF
35GF Score
INVO Fertility Inc IVF
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

INVO Fertility Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.1584 mean?
INVO Fertility (IVF) has a Beta of 2.1584 as of Jul. 11, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for INVO Fertility and its competitors.
Is INVO Fertility's Beta too high?
INVO Fertility's current Beta is 2.1584. Overall, INVO Fertility has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does INVO Fertility's Beta compare to RMSL and ADMT?
INVO Fertility's Beta of 2.1584 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for INVO Fertility and its competitors. INVO Fertility's current Beta is 2.1584. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is INVO Fertility stock overvalued right now?
Based on GuruFocus' analysis, INVO Fertility (IVF) is currently considered Possible Value Trap. The stock's GF Value™ is $134.71, compared to a current price of $1.13 — trading 99.2% below its estimated fair value. The current Beta is 2.1584. INVO Fertility's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For INVO Fertility (IVF), the current Beta is 2.1584 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is INVO Fertility (IVF) Overvalued in 2026?

Based on GuruFocus' analysis, INVO Fertility stock appears to be undervalued. The current stock price of $1.13 is trading 99.2% below its estimated GF Value™ of $134.71. GuruFocus considers INVO Fertility to be Possible Value Trap.

Key valuation signals for IVF:

  • Beta: 2.1584
  • GF Value™: $134.71 vs. price of $1.13 (99.2% below fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the IVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


INVO Fertility Business Description

Address 5582 Broadcast Court, Sarasota, FL, USA, 34240
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
35GF Score

Get the complete analysis for IVF

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13
Price
$134.71
GF Value